{{Rsnum
|rsid=11536879
|Gene=TLR4
|Chromosome=9
|position=117709933
|Orientation=plus
|GMAF=0.04913
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=TLR4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 94.7 | 4.4 | 0.9
| HCB | 78.1 | 21.9 | 0.0
| JPT | 82.3 | 15.9 | 1.8
| YRI | 99.3 | 0.7 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 78.1 | 21.9 | 0.0
| CHD | 85.3 | 13.8 | 0.9
| GIH | 90.1 | 8.9 | 1.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 84.5 | 15.5 | 0.0
| MKK | 98.7 | 1.3 | 0.0
| TSI | 98.0 | 2.0 | 0.0
| HapMapRevision=28
}}

{{PMID Auto
|PMID=19567509
|Title=Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.
|OA=1
}}

{{PMID Auto
|PMID=20200442
|Title=Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}